This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (23)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Neurology  • Alzheimer Disease  • Dementias  • Magnetic Resonance Imaging  • Aging/ Geriatrics  • Psychiatry, Other  • Alert me on articles by topic

Tom den Heijer, MD, PhD; Mirjam I. Geerlings, PhD; Freek E. Hoebeek, PhD; Albert Hofman, MD, PhD; Peter J. Koudstaal, MD, PhD; Monique M. B. Breteler, MD, PhD

Arch Gen Psychiatry. 2006;63:57-62.

Context  The recent focus on the development of preventive interventions for Alzheimer disease has fueled the search for biomarkers of presymptomatic disease. Patients with Alzheimer disease and mild cognitive impairment have marked atrophy of the hippocampus and amygdala compared with healthy elderly people. Whether atrophy of these structures is also present in persons without cognitive impairment who later develop dementia is unknown.

Objective  To assess whether volumetric assessment of the hippocampus and amygdala using magnetic resonance imaging (MRI) predicts dementia in elderly people without cognitive impairment.

Design  Longitudinal cohort study.

Setting  A general community in the Netherlands.

Participants  Five hundred eleven persons, aged 60 to 90 years, free of dementia at baseline were followed up during 3043 person-years (mean per person, 6.0 years). We performed volumetric assessment of the hippocampus and amygdala, obtained information about daily memory problems, and performed extensive neuropsychological testing in all study participants.

Main Outcome Measure  Dementia, as assessed by repeated neuropsychological screening and monitoring of medical records.

Results  Thirty-five persons developed dementia (26 with Alzheimer disease). Hippocampal and amygdalar volumes were strongly associated with the risk of dementia; the age-, sex-, and education-adjusted hazard ratio per 1-SD decrease in volume was 3.0 (95% confidence interval, 2.0-4.6) for the hippocampus and 2.1 (95% confidence interval, 1.5-2.9) for the amygdala. The hazard ratios associated with atrophy were similar in persons without memory complaints or low cognitive function at baseline. Compared with those remaining free of dementia, baseline brain volumes were 17% smaller in persons who received a clinical diagnosis of dementia within 2 to 3 years after MRI and still 5% smaller in those whose conditions were diagnosed 6 years after MRI.

Conclusion  Atrophy of the hippocampus and amygdala on MRI in cognitively intact elderly people predicts dementia during a 6-year follow-up.

Author Affiliations: Departments of Epidemiology and Biostatistics (Drs den Heijer, Geerlings, Hoebeek, Hofman, and Breteler) and Neurology (Drs den Heijer and Koudstaal), Erasmus Medical Center, Rotterdam, the Netherlands; and Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht, the Netherlands (Dr Geerlings).

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

History of depression, depressive symptoms, and medial temporal lobe atrophy and the risk of Alzheimer disease
Geerlings et al.
Neurology 2008;70:1258-1264.
ABSTRACT | FULL TEXT  

Role of imaging techniques in the diagnosis of dementia
O'BRIEN
Br. J. Radiol. 2007;80:S71-S77.
ABSTRACT | FULL TEXT  

Plasma folate concentration and cognitive performance: Rotterdam Scan Study
de Lau et al.
Am. J. Clin. Nutr. 2007;86:728-734.
ABSTRACT | FULL TEXT  

The Association of Polymorphisms in the Type 1 and 2 Deiodinase Genes with Circulating Thyroid Hormone Parameters and Atrophy of the Medial Temporal Lobe
de Jong et al.
J. Clin. Endocrinol. Metab. 2007;92:636-640.
ABSTRACT | FULL TEXT  

Thyroid Hormones, Dementia, and Atrophy of the Medial Temporal Lobe
de Jong et al.
J. Clin. Endocrinol. Metab. 2006;91:2569-2573.
ABSTRACT | FULL TEXT